Navigation Links
Uroplasty Reports Financial Results for the Second Quarter FY2011
Date:10/27/2010

eds from sale of short-term investments

2,500,0002,500,000Purchase of short-term investments

(5,000,000)(2,000,000)Purchases of property, plant and equipment

(94,506)(61,334)Purchases of intangible assets

(11,300)-Proceeds from sale of property, plant and equipment

-2,000Net cash (used in) provided by investing activities

(2,605,806)440,666Cash flows from financing activities:Net proceeds from public offering of common stock

14,917,059-Net proceeds from warrant and option exercise

2,275,906-Net cash provided by financing activities

17,192,965-Effect of exchange rates on cash and cash equivalents

(28,674)34,771Net increase (decrease)  in cash and cash equivalents

13,076,418(1,483,432)Cash and cash equivalents at beginning of period

2,311,2693,276,299Cash and cash equivalents at end of period

$15,387,687$1,792,867Supplemental disclosure of cash flow information:Cash paid during the period for interest

$-$6,145Cash received(paid) during the period for income taxes

248(105,877)Non-GAAP Financial Measures:  The following table reconciles our operating loss calculated in accordance with accounting principles generally accepted in the U.S. (GAAP) to non-GAAP financial measures that exclude non-cash charges for share-based compensation, and depreciation and amortization expenses from gross profit, operating expenses and operating loss.  The non-GAAP financial measures used by management and disclosed by us are not a substitute for, or superior to, financial measures and consolidated financial results calculated in accordance with GAAP, and you should carefully evaluate our reconciliations to non-GAAP.  We may calculate our non-GAAP financial measures differently from similarly titled measures used by other companies.  Therefore, our non-GAAP financial measures may not be comparable to those used by other companies.  We have described the rec
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Uroplasty to Issue Second Quarter 2011 Results on October 27, 2010
2. Uroplasty to Present at The 5th Annual JMP Securities Healthcare Conference
3. Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplastys Urgent® PC Neuromodulation System
4. Uroplasty to Present at Global Hunter Securities Inaugural Healthcare Conference
5. Uroplasty Reports Results for Second Quarter FY2010
6. Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009
7. Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence
8. Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial
9. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
10. Endologix Reports 30% Third Quarter 2010 Revenue Growth
11. Pharmos Corporation Reports 2010 Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... N.C. , Aug. 28, 2015  Delays ... research projects can slow down the decision-making process, ... is, therefore, absolutely critical for biopharmaceutical companies to ... research approval process for quicker and more meaningful ... by Best Practices, LLC, nearly three-quarters of benchmarked ...
(Date:8/28/2015)... , August 28, 2015 ... Market by Tumor (Breast, Lung, Prostate) Type (Protein & ... (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast ... is expected to reach around 17,689.0 Million USD by ... period of 2015 to 2020. Browse ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/686gwf/investigation ... Report on China,s Bevacizumab Market ,2010-2019" report to ... trade name of Avastin, bevacizumab injection is the first ... was approved by CFDA to treat metastatic colorectal cancer. ... all come from Roche and its subsidiary Genectech. ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Bevacizumab Market 2015-2019 2
... June 15 Halt Medical, Inc., today announced that the ... Electrosurgical System for soft tissue ablation using radiofrequency energy.  "This clearance ... investors," said Russ DeLonzor , President and Chief Operating Officer.  ... Radiofrequency ...
... WAYNE, N.J. , June 15 Today, Bayer HealthCare ... Inc., Barr Pharmaceuticals LLC, and Barr Laboratories, Inc. in the Northern ... and patent infringement in connection with Teva,s generic oral contraceptive, Gianvi™. ... leading oral contraceptive YAZ ® .   , ...
Cached Medicine Technology:Halt Medical, Inc. Receives FDA Clearance 2Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 2Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 3Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 4Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 5
(Date:8/29/2015)... ... August 29, 2015 , ... "I have been ... Place, N.Y. "I specialize in manual therapy, and my invention will provide headache ... used for additional muscle dysfunction throughout the body." , They developed THE RELIEVER ...
(Date:8/29/2015)... York, NY (PRWEB) , ... August 29, 2015 , ... ... unofficial end of summer (which astronomically, officially ends on September 22nd this year). For ... summer-induced cyber security hangovers linger on which could prove far more costly than a ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences ... sell Arterosil and Arterosil HP, and that all claims and counterclaims have been ... Sciences, LLC (VHS) in the United States District Court for the Southern District ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department ... qualified for the position they are applying for, they are unable to pass the ... are considering altering drug testing policies in order to be able to hire long-term, ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a non-invasive ... two years, the longest of any cellulite reduction system currently on the market. ... solution for their cellulite, according to Dr. Robert Weiss, director of the premier MD ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
... work Scientists now been able to map the most common ... face of future medicine. ,The study called 'HapMap' study ... genetic differences between 269 individuals that originate from different ... Western Europe. The study involved more than 200 scientists ...
... tea is produced from the leaves of the evergreen ... green tea are polyphenolic compounds, known as catechins. Catechins ... dry // ht, including (-)-epigallocatechin gallate (EGCG), (-)-epigallocatechin ... accounts for approximately 50% of the total amounts of ...
... which can be used to reveal the strength of ... assessing// the likelihood of fracturing a particular bone, an ... Research, says. ,Scientists have developed a laser imaging ... bone density thereby predicting future risk of fracturing that ...
... A bacterium strain known as Helicobacter pylori may raise ... study.// ,Two-thirds of the world population carries H. ... for 25 percent of all childhood cancers worldwide. Acute ... childhood leukaemia. ,Clusters of ALL often occur in ...
... The discovery by a young boy of 22 dead geese at ... may have already found its way into the country, though officials ... the town of Neuwied wore biological protection suits to scoop up ... them in metal boxes to the laboratory in nearby Koblenz run ...
... contamination in herbal/ayurvedic medicines, testing of levels of such ... Indian Government has already issued a notification to test ... meant for products meant for export. It is likely ... as well. ,The Department of Ayurveda, Yoga ...
Cached Medicine News:Health News:Catechins in green tea show antiviral effect on influenza virus 2Health News:Birds Flu Scare Reaches Germany 2
... The model 55S Rocking Shaker ... gels and blotted membranes. The very ... adjustable degree of tilt provide a ... washes over gels and blotted membranes ...
... Labsystems Wellmix is a high-quality four-place microplate ... The shaking speed is adjustable from 100 ... speed and a small orbit ensure effective ... time is quick and easy to set ...
... 96 can incubate and shake up to 16 ... at a time. This new system is ... such as Proteinase K digestion. Now you ... preparing your samples with our AutoIncubator 96 and ...
Inquire...
Medicine Products: